Analysis finds meaningful impact on pharmaceutical innovation from reduced revenues
A new white paper from the USC Schaeffer Center for Health Policy & Economics shows that for every 10% reduction in expected revenues from prescription drug prices in the United States, innovation — such as … Read More »